BBA
AUXL

Baker Bros. Advisors’s AUXILIUM PHARAMCEUTICALS INC AUXL Stock Holding History

Baker Bros. Advisors’s Portfolio AUXL Stock Details AUXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-58,544
Closed -$1.59M – 112
2014
Q1 		$1.59M Buy
+58,544
New +$1.55M 0.02% 91

Other funds holding AUXL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Baker Bros. Advisors's AUXL Position: Q2 2014 in Review

Baker Bros. Advisors sold out of AUXILIUM PHARAMCEUTICALS INC (AUXL) in Q2 2014, closing a stake of 58,544 shares — an estimated $1.59M sold.

Baker Bros. Advisors first reported a position in AUXL in Q1 2014 and held it in 1 quarter. The position peaked at $1.59M in Q1 2014. 152 funds tracked by Wall St. Rank hold AUXL as of Q2 2014.

  • Baker Bros. Advisors reported no remaining AUXILIUM PHARAMCEUTICALS INC position as of Q2 2014 after selling out during the quarter.
  • Baker Bros. Advisors sold 58,544 AUXILIUM PHARAMCEUTICALS INC shares in Q2 2014, an estimated $1.59M.
  • Baker Bros. Advisors first reported a position in AUXILIUM PHARAMCEUTICALS INC in Q1 2014 and held it in 1 quarter.
  • Baker Bros. Advisors's AUXILIUM PHARAMCEUTICALS INC position peaked at $1.59M in Q1 2014.
  • 152 funds tracked by Wall St. Rank held AUXILIUM PHARAMCEUTICALS INC as of Q2 2014.

Based on Baker Bros. Advisors's 13F filing for Q2 2014, filed 14 Aug 2014.